Abbott Showcases Over 100 Cutting-Edge Medical Technologies at CIIE, Nearly 40% Making China Debut

Shanghai Securities News China Securities Network (Reporter Song Weiping) At the ongoing 3rd China International Import Expo (hereinafter referred to as the CIIE), Fortune Global 500 companiesAbbottAbbott made its debut at the China International Import Expo, showcasing more than 100 cutting-edge medical technologies.

It is reported that Abbott’s total exhibition area exceeds 600 square meters, presented in a dual-booth format across the Medical Devices and Pharmaceuticals & Healthcare Zone and the Special Zone for Public Health and Epidemic Prevention. The display comprehensively showcases Abbott’s diverse, cutting-edge medical technologies in its four core sectors—diagnostics, medical devices, nutritionals, and pharmaceuticals—as well as its advanced products and technologies widely deployed during the global fight against the pandemic.

Shanghai Securities News reporter learned that among the more than 100 exhibits displayed by Abbott, nearly 40% made their China debut, including several world-first innovations.

In the field of diabetes management, Abbott introduced its groundbreaking FreeStyle Libre Flash Glucose Monitoring System, which eliminates the need for fingerstick blood glucose testing. In the realm of vascular and cardiac diseases, Abbott presented comprehensive solutions spanning from peripheral to cardiovascular and cardiac care, and covering diagnosis, treatment, and prognosis.

As a leader in the diagnostics field, Abbott also introduces innovative testing and diagnostic systems that provide timely and accurate information for patients and physicians. Among these, the Alinity ci integrated clinical chemistry and immunoassay solution helps medical laboratories and healthcare institutions comprehensively and quantifiably enhance their medical performance management from multiple perspectives, including consistency, flexibility, efficiency, and reliability.

In the nutritional products sector, Abbott showcased high-quality nutritional solutions covering the entire life cycle and tailored to the dietary needs of diverse populations, including several products making their debut in China via cross-border e-commerce platforms.

In the “Public Health and Epidemic Prevention” section, Abbott will showcase its advanced COVID-19 testing technologies, medical nutrition products, and diabetes management solutions that have been widely used in the global fight against the pandemic. It is reported that Abbott has developed and launched several testing technologies and products for different platforms and scenarios, including rapid COVID-19 testing technologies that can be used at the frontlines and central hubs of epidemic prevention and control.